Initial Management of Acute Ischemic Stroke, Left Corona Radiata
Patients with acute ischemic stroke in the left corona radiata should receive intravenous recombinant tissue plasminogen activator (rtPA) at 0.9 mg/kg (maximum 90 mg) if they present within 4.5 hours of symptom onset and have no contraindications. 1, 2
Immediate Assessment and Stabilization
- All patients with suspected acute ischemic stroke should undergo immediate neurological evaluation using a validated stroke severity scale such as NIHSS 3, 2
- Urgent brain imaging (CT or MRI) must be performed to rule out hemorrhage and determine eligibility for reperfusion therapies 3, 2
- Maintain airway, breathing, and circulation, with supplemental oxygen to maintain saturation ≥94% 2
- Monitor vital signs frequently, with initial checks every 15 minutes during and after rtPA infusion for 2 hours, then every 30 minutes for 6 hours, then hourly until 24 hours after treatment 1
Blood Pressure Management
- For patients eligible for thrombolysis, blood pressure must be <185/110 mmHg before administering rtPA 1, 2
- If blood pressure exceeds this threshold, use the following medications to lower it:
- After rtPA administration, maintain blood pressure ≤180/105 mmHg 1, 3
- For patients not receiving reperfusion therapy, avoid treating hypertension unless systolic BP >220 mmHg or diastolic BP >120 mmHg 1, 2
Reperfusion Therapy
- Intravenous rtPA (0.9 mg/kg, maximum 90 mg) with 10% given as bolus over 1 minute and remainder infused over 60 minutes is the standard treatment for eligible patients within 4.5 hours of symptom onset 1, 4
- If the patient presents within 3 hours of symptom onset, the benefit of rtPA is strongest (Grade 1A evidence) 1, 5, 6
- For patients presenting between 3-4.5 hours, rtPA is still beneficial but with more selective criteria (excluding patients >80 years old, those with NIHSS >25, those taking oral anticoagulants even with INR <1.7, and those with both previous stroke and diabetes) 1
Endovascular Therapy Consideration
- For patients with large vessel occlusion (which may be the cause of corona radiata infarct), mechanical thrombectomy should be considered, particularly if:
- Stent retrievers such as Solitaire FR and Trevo are preferred over coil retrievers for mechanical thrombectomy 1
Antithrombotic Therapy
- For patients not receiving thrombolysis, administer aspirin (initial dose 325 mg) within 24-48 hours after stroke onset 1, 5, 6
- Aspirin should NOT be administered within 24 hours of rtPA administration 1
- Clopidogrel and glycoprotein IIb/IIIa inhibitors are not recommended in the acute phase 1
Management of Physiological Parameters
- Monitor blood glucose regularly and treat hyperglycemia to maintain levels <300 mg/dL 3, 2
- Identify and treat sources of fever, using antipyretics for temperatures >37.5°C 3, 2
- For patients with restricted mobility, use prophylactic low-dose subcutaneous heparin or low molecular weight heparins to prevent deep vein thrombosis 1, 5, 6
Management of Complications
- Corticosteroids are NOT recommended for cerebral edema and increased intracranial pressure following ischemic stroke 1, 2
- For patients deteriorating due to increased intracranial pressure, use osmotherapy and hyperventilation 1, 2
- Surgical decompression may be necessary for large cerebellar infarctions causing brainstem compression 1, 3
- Treat recurrent seizures as with any other acute neurological condition, but prophylactic anticonvulsants are not recommended 1
Early Rehabilitation
- Initial assessment by rehabilitation professionals should be conducted within 48 hours of admission 3, 2
- Begin rehabilitation therapy as soon as the patient is medically stable 3, 2
- Start frequent, brief, out-of-bed activity within 24 hours if no contraindications exist 3, 2
Common Pitfalls to Avoid
- Delays in treatment significantly worsen outcomes - every 30-minute delay in recanalization decreases the chance of good functional outcome by 8-14% 3, 2
- Inadequate blood pressure control before thrombolysis increases hemorrhagic risk 3, 2
- Failure to monitor for and treat complications (swallowing difficulties, infections, venous thromboembolism) can worsen outcomes 3
- Overly selective treatment criteria may exclude patients who could benefit from therapy 2